CORD-19:775b90287b44353bee979abb0970a4666022f86d / 397827-398006 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T34091","span":{"begin":0,"end":179},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Patients present with rash, fever, hypereosinophilia, lymphadenopathy, and internal organ involvement, often hepatitis, usually within two months after initiation of a medication."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T319","span":{"begin":0,"end":179},"obj":"Sentence"}],"text":"Patients present with rash, fever, hypereosinophilia, lymphadenopathy, and internal organ involvement, often hepatitis, usually within two months after initiation of a medication."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2792","span":{"begin":54,"end":69},"obj":"Disease"},{"id":"T2793","span":{"begin":109,"end":118},"obj":"Disease"},{"id":"T77102","span":{"begin":54,"end":69},"obj":"Disease"},{"id":"T46140","span":{"begin":109,"end":118},"obj":"Disease"}],"attributes":[{"id":"A2792","pred":"mondo_id","subj":"T2792","obj":"http://purl.obolibrary.org/obo/MONDO_0005833"},{"id":"A2793","pred":"mondo_id","subj":"T2793","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"},{"id":"A17641","pred":"mondo_id","subj":"T77102","obj":"http://purl.obolibrary.org/obo/MONDO_0005833"},{"id":"A19333","pred":"mondo_id","subj":"T46140","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"}],"text":"Patients present with rash, fever, hypereosinophilia, lymphadenopathy, and internal organ involvement, often hepatitis, usually within two months after initiation of a medication."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T1919","span":{"begin":22,"end":26},"obj":"Phenotype"},{"id":"T1920","span":{"begin":28,"end":33},"obj":"Phenotype"},{"id":"T1921","span":{"begin":35,"end":52},"obj":"Phenotype"},{"id":"T1922","span":{"begin":54,"end":69},"obj":"Phenotype"},{"id":"T1923","span":{"begin":109,"end":118},"obj":"Phenotype"}],"attributes":[{"id":"A1919","pred":"hp_id","subj":"T1919","obj":"http://purl.obolibrary.org/obo/HP_0000988"},{"id":"A1920","pred":"hp_id","subj":"T1920","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A1921","pred":"hp_id","subj":"T1921","obj":"http://purl.obolibrary.org/obo/HP_0032061"},{"id":"A1922","pred":"hp_id","subj":"T1922","obj":"http://purl.obolibrary.org/obo/HP_0002716"},{"id":"A1923","pred":"hp_id","subj":"T1923","obj":"http://purl.obolibrary.org/obo/HP_0012115"}],"text":"Patients present with rash, fever, hypereosinophilia, lymphadenopathy, and internal organ involvement, often hepatitis, usually within two months after initiation of a medication."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T654","span":{"begin":84,"end":89},"obj":"Body_part"}],"attributes":[{"id":"A654","pred":"uberon_id","subj":"T654","obj":"http://purl.obolibrary.org/obo/UBERON_0000062"}],"text":"Patients present with rash, fever, hypereosinophilia, lymphadenopathy, and internal organ involvement, often hepatitis, usually within two months after initiation of a medication."}